Addressing limitations is critical to using CRISPR to treat disease
Many benefits make it worth considering for your next experiment
Expanding toolkit being used to reveal cell and disease mechanisms.
High-content readouts and HT genetic screening are now possible.
Novel approach can translate to an increased chance of success
Discover the trends playing out in drug discovery labs today.
Capabilities create nearly limitless possibilities for drug discovery.
iPSCs show promise as neurological models for use in screens.
Inherent flexibility means that a range of HT screens are available.
Multiplexed screening strategies have a myriad of benefits.